PBMCs were purified from peripheral blood of 16 CLL patients with stable disease and transiently transfected with short interfering RNA (siRNA) targeting ZNF224 or with scramble siRNA as negative control. This evidence concerns the gene ZNF224 and B-cell chronic lymphocytic leukemia.